[Peritoneovenous shunt in the treatment of therapy resistant ascites. Results of 7 years' experience].
In recent years, implantation of a peritoneo-venous shunt has proven effective in the treatment of therapy-resistant ascites. From 1976 till 1983, a total of 63 shunt systems (Le Veen-, Agishi -, Denver system) were implanted in 55 patients with a mean age of 52.3 years. The most common cause for ascites was hepatic cirrhosis. The average functional period amounted to 21.7 months and the longest implantation time to nearly 7 years. The postoperative complication rate is considerable: 19 patients died in the postoperative course. The most dreaded complication is shunt infection and intravascular thrombopathy . In spite of the high complication rate, the establishment of a peritoneo-venous shunt is recommendable for combatting therapy-resistant ascites.
D000328:Adult; D000368:Aged; D001201:Ascites / Q000188:drug therapy; D004351:Drug Resistance; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010536:Peritoneovenous Shunt / Q000295:instrumentation / Q000379:methods; D014656:Vascular Surgical Procedures / Q000379:methods
Der peritoneo-venöse Shunt zur Behandlung des therapieresistenten Ascites. Ein siebenjähriger Erfahrungsbericht.